share_log

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights

SEC ·  May 10 05:08
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.